Author

A. Vasquez-Salgado

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

A. M. Zahm· 1 shared D. Ackerman· 1 shared K. H. Kaestner· 1 shared K. J. Wangensteen· 1 shared M. E. Preziosi· 1 shared T. Gade· 1 shared

Activity by Year

2019-2019 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. M. Zahm

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

In vivo screen identifies LXR agonism potentiates sorafenib killing of hepatocellular carcinoma

M. E. Preziosi, A. M. Zahm, A. Vasquez-Salgado, D. Ackerman, T. Gade, K. H. Kaestner, K. J. Wangensteen

The paper identifies LXR agonism as a potential enhancer of sorafenib's efficacy in treating hepatocellular carcinoma through an in vivo genetic screen and mechanistic studies.

bioRxiv · Jun 13, 2019 · PreprintCancer Biology